Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Fibroblasts can be turned into melanocytes for potential skin treatments.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Neurosteroids show promise for treating epilepsy and more research is needed.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Genetics and hormones cause hair loss; finasteride treats it safely.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Fullerene nanomaterials help hair grow faster and increase hair follicles.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.